SandboxAQ announced a collaboration with the Mayo Clinic to advance its CardiAQ platform, studying how findings from magnetocardiography (MCG), a method that reads the heart's magnetic field rather than its electrical signals, compare with angiography, the standard imaging test used to spot blocked arteries. The goal is to establish MCG, paired with SandboxAQ's AI analysis, as a non-invasive way to flag cardiac problems without contrast dye or radiation exposure. The collaboration adds a major academic medical center to SandboxAQ's effort to validate CardiAQ in real clinical settings. SandboxAQ is a Parkway Venture Capital portfolio company.
Read the full article: SandboxAQ's announcement of the Mayo Clinic collaboration
Share
Greatness lies ahead
Sign up for updates from the cutting edge of deep tech venture capital.
You’re on the list!
Something went wrong while submitting the form.





